SYNTOPIX, the university spin-out specialising in developing treatments for skin conditions, today brought in a City heavyweight as its chairman as part of a restructuring of its board of directors.

The Bradford-based AIM-listed group has appointed former investment banker and hedge fund executive Tom Bannatyne, who has replaced Dr Rod Adams as chairman.

The move will also see co-founder Dr Anne Eady and Dr Helen Shaw step down as non-executive directors although Dr Eady will continue in her role as scientific direct......for the full story register now for free or login below...